INTRODUCTION
Diabetes mellitus is one of the most common endocrine and metabolic disorders affecting over 170 million people worldwide [1, 2] . Insulin resistance is a key phenomenon in the pathogenesis of type 2 diabetes and is usually associated with the obesity, dyslipidaemia and hypertension. Insulin resistance, characterised by hyper-insulinemia, hypertriglyceridemia and hypertension, has been reported in primary normoglycaemic and normotensive, genetically non-susceptible Sprague-Dawley rats fed high sucrose or fructose diets [3, 4] . Increased fructose consumption, on the other hand, has been associated with obesity epidemic as well as metabolic syndrome [5, 6] . Fructose-rich and high fat diets, commonly consumed in emerging urban areas, has been associated with increased prevalence of overweight/obesity and diabetes in these communities [7] .
Among the many challenges faced by developing countries in the face of rapid urbanization is the need for medications to address emerging diseases such as diabetes mellitus. To address this need, indigineous knowledge is often referred to, including the use of extracts from medicinal plants. Several plant extracts are reported to have hypoglycaemic effect including Bridelia ferruginea (Euphorbiaceae) [8] -a woody shrub which grows in the Savannah or rain forests of Africa. Traditionally, B. ferruginea bark extract is used as a milk coagulant, mouth wash, purgative and vermifuge. It is also used for the treatment of diabetes, arthritis and boils. Extracts of the plant have been shown to have molluscidal effect [9] , antibacterial activity [10] , anti-inflammatory property [11] and hypoglycaemic effect [12] . Several compounds with cytotoxic and cytostatic activity on tumor cell lines, such as β-peltatin-5-O-β-D-glucopyranoside, deoxypodophyllotoxin and 5'demethoxy-β-peltatin-5-O-β-D-glucopyranoside, have been isolated from B. ferruginea [13] ; so also is the biflavanol gallocatechim- [4-O-7] -epigallocatechim [14] . Although this plant extract has been shown to have hypoglycaemic effect, its effect has not been studied in sucroseinduced glucose intolerance. The objective of the present study was, therefore, to induce glucose intolerance in normal Wistar rats using sucrose loading and to investigate the hypoglycaemic effect of the methanol leaf extract of Bridelia ferruginea in the rats.
EXPERIMENTAL Plant material
Bridelia ferruginea was collected in May 2000 in Yaoundé -Cameroon. It was identified and authenticated by Mr Nana, a taxonomist at the Cameroon National Herbarium in Yaoundé where a voucher specimen (32266/HNC) was deposited. Air-dried and powdered leaves (1 kg) were extracted with methanol at room temperature for 72 h followed by evaporation of the solvent under reduced pressure using a Büchi Rota-vapor (Bioblock, Illkirch-France). A greenish crude extract (80 g) was obtained, from which test solutions of the required concentrations were prepared in Tween 80/ethanol/water (1:1:10) for subsequent evaluation.
Drugs
Tolbutamide and metformin, used in these experiments were obtained from Norvo Nordisk.
Experimental animals
Six to seven week-old male Wistar rats, weighing 140 -160 g, were used in these experiments. 
Induction of glucose intolerance
At the start of the experiment, baseline fasting blood glucose level was determined for all animals after a 12-h fast. A spectrophotometer, Hemocue R B-Glucose Analyser (Angelholm, Sweden), was used to measure blood glucose levels in whole capillary blood obtained by puncturing the tail vein. Animals with normal blood glucose levels were then randomly allocated to each of four experimental groups (5 rats/group). The control group was fed regular laboratory rat chow (standard diet) consisting of 58.1 % wheat flour, 5.8 % corn flour, 7.0 % ground palm nut extract, 11.6 % ground cotton nuts, 5.8 % powdered bone and 11.7 % ground smoked fish. The other three groups were placed on experimental diets, consisting of the standard diet enriched with 35, 50 or 65 % (w/w) sucrose, respectively (hereafter referred to as sucrose diets). Blood glucose levels were determined for all animals weekly during the 8-week diet period.
Glucose tolerance test
After 2 weeks on assigned diets, fasting blood glucose levels were determined in control and 50 % sucrose-fed animals. These animals were then orally challenged with 3 g glucose/kg and fasting blood glucose levels determined 30 min, 1 and 2 h after glucose administration.
Assessment of hypoglycaemic effect of single dose of drugs
Whole capillary blood glucose levels were determined using a blood glucose spectrophotometer, after an overnight fast. Glucose concentration was measured at time 0 h, i.e., just before administration of the drugs and then at 30 min intervals for 24 h after drug administration to the groups which received either tolbutamide (50 mg/kg) or 50 mg/kg of (MEBF). For the group which received metformin (38 mg/kg), blood glucose level was measured after 2, 4, 6, 12, 18 and 24 h post-treatment. Animals which received insulin (4 U) were tested before insulin administration and also 2 h after insulin administration.
Hypoglycemic and lipid-lowering effects of MEBF
The animals which showed glucose intolerance after the 8-week dietary period were used for this experiment. Ten of these rats were maintained on 50 % sucrose enriched diet and allocated to one of the two groups -5 to the control group which received no treatment and 5 to the group treated daily for 6 days with MEFB (50 mg/kg). Serum glucose concentration, triglycerides and total cholesterol were determined before treatment and after 6 days of treatment after a 12 h fast. Briefly, serum total cholesterol, HDL cholesterol and triglycerides levels were measured in animals enzymatically using Cobas Mira S analyzer with kits purchased from Biolabo (France). LDL-choloesterol was calculated from concentrations of total cholesterol, HDL cholesterol and triglycerides according to Friedewald [16] .
Measurement of insulin secretion
Pancreatic islet cells from NMRI mice (Charles River, Sulzfeld, Germany) were used for these experiments. Mice were sacrificed by inhalation of excess CO 2 and batches of 5 pancreatic islets isolated microscopically and incubated for 60 min at 37 °C with 3 or 15 mM glucose. The incubation medium (pH 7.4) contained (in mMol/l): 122 NaCl, 4.8 KCl, 2.5 CaCl 2 , 1.1 MgCl 2 , 10 (4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES), as well as 0.5 % bovine serum albumin. The plant extract was added at different concentrations in the presence of 3 or 15 mM glucose. The amount of insulin secreted was determined by radioimmunoassay using rat insulin (Crystal Chem. Inc., USA) as standard.
Statistical analysis
GraphPad Instat was used to carry out oneway analysis of variance (ANOVA) followed by Tukey-Kramer Multiple Comparisons Test. For data on insulin secretion, multiple comparisons were made by ANOVA followed by Student-Newman-Keuls test. The results are expressed as mean ± standard error. A pvalue of < 0.05 was considered significant.
RESULTS

Effect of diet on glucose tolerance
Baseline fasting blood glucose levels in normoglycemic rats were between 45 -52 mg/dL. Sucrose diets induced significant increases in the mean blood glucose concentration. Animals fed 35% and 50% sucrose showed significant (p<0.05) increases in blood glucose levels from week 5 while animals fed 65% sucrose showed significant (p<0.05) increase in blood sugar levels only during weeks 2 and 6 ( Table 1) . Animals fed 50% sucrose diet showed mild levels of hyperglycaemia during the first week of the diet. Although this hyperglycaemia resolved during week 2 week on this diets, the oral glucose tolerance test indicated that there was an impaired glucose tolerance in these animals ( Table 2 ). Animals on sucrose diets had higher glucose levels which remained significantly higher beyond 2 hours after the glucose challenge.
Hypoglycaemic effect of single dose of extract and reference drugs
The hypoglycaemic activity of porcine insulin (4 U/rat) on sucrose-treated (50 %) glucoseintolerant rats is shown in Table 3 . Insulin significantly (p < 0.01) reduced blood glucose levels in both normoglycemic and sucrosefed, glucose-intolerant animals.
In normoglycaemic rats, insulin reduced glycaemia by 64.5 %, compared to 52.3 % in sucrose-fed rats (Table 3) . Insulin therefore achieved a better hypoglycaemic effect 2 h after administration compared to tolbutamide (28 %), metformin (7 %) and MEBF (-0.3 %) during a similar period. In 50% sucrose-fed glucose intolerant rats, tolbutamide induced rapid onset but short lasting hypoglycaemic effects compared to metformin whose effects were of a later onset but more long lasting. Similarly, hypoglycaemic effects of MEBF were of a late onset though it lasted for over 6 hours (Fig. 1) . Table 2 : Mean whole blood glucose concentration (mean  SD, n = 5) after oral glucose (3g/kg) challenge. Sucrose fed animals had been on the 50% sucrose diet for 2 weeks.
Blood glucose (mg/dL) Time (h)
Control rats
Sucrose-fed rats 
Effect of 50 % sucrose diet on fasting blood glucose and lipid levels
The mean serum glucose level of the sucrose-fed rats was 167  19 mg/dL, while a value of 120.7  5.7 mg/dL was obtained for their age, sex and weight matched controls fed standard diet (Fig 2a) . Total serum cholesterol level was significantly higher (p < 0.05) in sucrose-fed rats than in control rats, while serum triglyceride levels were 280.7  23.1 and 169  17.1 mg/dL (p < 0.05) in 50 % sucrose-fed and control rats, respectively. The 50 % sucrose diet significantly (p < 0.05) increased blood glucose, serum triglyceride and total cholesterol levels 
Effect of 6-day treatment with MEBF on blood glucose and lipid levels
After 6 days of oral MEBF treatment (50 mg/kg/day), fasting blood glucose levels in 50 % sucrose-fed rats decreased significantly (p < 0.05) to levels similar to those observed in control animals (126.4 ± 2.9 versus 167.7 mg/dL ± 13 for control). Sucrose-fed rats treated with MEBF significantly (p < 0.05) reduced serum triglyceride and total cholesterol relative to control values. Although both triglyceride and total cholesterol levels were significantly reduced by MEBF, post-treatment levels were not different from pre-treatment levels in control animals (Fig 2b) . 
Effect of MEBF extract on insulin secretion
MEBF, at all dose levels tested, did not induce any significant effect (p < 0.05) on insulin secretion.
DISCUSSION
The results presented demonstrate that rats fed sucrose-rich diets for 8 weeks developed higher fasting blood glucose concentrations. After 2 weeks of ingesting sucrose-enriched diet, the rats showed intolerance to glucose as indicated by the oral glucose tolerance test. Blood glucose levels were significantly higher from the 5 th week of sucrose enriched diet, indicating that the impairment of glucose homeostasis is dependent on the duration of exposure to large amounts of sucrose.
When sucrose is consumed, it is broken down to glucose and fructose. Absorbed fructose is converted to lipogenic precursors leading to increase in plasma triglyceride levels [17, 18] . Our results show that at the end of the 8-week diet period, total cholesterol and triglyceride levels were significantly higher in sucrose-fed rats, compared to control. High fructose diets are associated with increased serum triglyceride [19] and total cholesterol [18] levels. Longterm effects of fructose administration include significant lipotoxicity and hepatic insulin resistance which may eventually lead to a more generalized insulin resistance [20, 21] ; this was reflected by the significantly higher blood glucose levels in sucrose-fed animals.
Unlike glucose, fructose does not induce the release of insulin or leptin, both of which are necessary for glucose handling [19] . Importantly, Wei et al [22] reported that fructose administration may cause oxidative stress leading to the release of reactive oxygen species which, in turn, may be associated with impaired insulin signalling. This observation is in agreement with our findings which show that sucrose-fed rats had higher blood glucose levels when challenged with oral glucose, indicating impairment in glucose handling mechanisms. The administration of insulin to sucrose-fed rats induced a smaller glucose lowering effect compared to control, suggesting that the sucrose-fed rats had developed impaired response to insulin action. Consistent with this observation, metformin, which acts by increasing insulin-mediated glucose uptake by cells [23] , failed to show significant hypoglycaemic activity in sucrose-fed animals until 18 h post-metformin administration.
MEBF extract exhibited significant hypoglycaemic activity in sucrose-fed, glucose-intolerant rats compared to control rats, indicating that this extract may contain metabolites with anti-diabetic properties. Cholesterol as well as triglyceride levels were also decreased in these rats compared to untreated animals. These two observations suggest that B. ferruginea leaf extract lowers blood glucose concentration by improving insulin sensitivity and not by stimulating insulin secretion.
CONCLUSION
The leaf extract of Bridelia ferruginea exhibited hypoglycaemic effects in sucroseinduced glucose intolerant rats as well as improved lipid profiles. However, further studies are required to ascertain if these findings can be translated to applications.
